INVEST IN
THE FUTURE

Over the last fifteen years, countries have begun to accept and legalise the sale of medical cannabis. This trend is expected to continue; Oceania’s market is quickly opening with a forecast figure of USD2.5b by 2028.

DOMESTIC MARKET

The April 2020 legalisation of medicinal cannabis in New Zealand offers new enterprise opportunities in this nascent market. Clear regulations, standards, and protocols established under the NZ Medicinal Cannabis Agency, a part of the Ministry of Health, has laid the foundation for a NZD25m (USD18m) medicinal cannabis flower market by 2024.

EXPORT MARKET

Medical cannabis market capitalisation in Europe is expected to rise to NZD3.3b (USD2.4b) by 2024, with demand in established jurisdictions in Germany, Italy, and UK steadily growing. New markets are expected to legalise medical cannabis before 2024, including France and Spain. Both dried flower and extract sales are expected to grow by 600% over the next 4 years.

KEYS TO SUCCESS

By creating our own distribution and patient access ecosystem, we will implement a Capex light and upstream business model, allowing us to rapidly build our reputation and gain substantial market share.

Contact us today for more information on investment opportunities and other commercial aspects of medicinal cannabis. We will respond to your query as soon as possible.

Naativv Bioscience logo in black

© 2024 NAATIVV BIOSCIENCE